CoChat

Inhibition of insulin resistance by PGE1 via autophagy-dependent FGF21 pathway in diabetic nephropathy

Open access
Wei, Wei, An, Xing-Rong, Jin, Shi-Jie, Li, Xiao-Xue, Xu, Ming · 2018 · Scientific Reports
Cited by 117

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Insulin resistance is a critical process in the initiation and progression of diabetic nephropathy (DN). Alprostadil (Prostaglandin E1, PGE1) had protective effects on renal function. However, it is unknown whether PGE1 inhibited insulin resistance in renal tubule epithelial cells via autophagy, which plays a protective role in DN against insulin resistance. Insulin resistance was induced by palmitic acid (PA) in human HK-2 cells, shown as the decrease of insulin-stimulated AKT phosphorylation, glucose transporter-4 (GLUT4), glucose uptake and enhanced phosphorylation of insulin receptor substrate 1(IRS-1) at site serine 307 (pIRS-1ser307) and downregulated expression of IRS-1. Along with less abundance of p62, autophagy markers LC3B and Beclin-1 significantly increased in HK-2 cells exposed to PA. Such abnormal changes were significantly reversed by PGE1, which mimicked the role of autophagy gene 7 small interfering RNA (ATG7 siRNA). Furthermore, PGE1 promoted the protein expression of autophagy-related fibroblast growth factor-21 (FGF21), which alleviated insulin resistance. Results from western blotting and immunohistochemistry indicated that PGE1 remarkably restored autophagy, insulin resistance and the FGF21 expression in rat kidney of type 2 diabetes mellitus (T2DM). Collectively, we demonstrated the potential protection of PGE1 on insulin resistance in renal tubules via autophagy-dependent FGF21 pathway in preventing the progression of DN.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-18427-2

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 47

  1. Gnudi, L., Coward, R. J. & Long, D. A. Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms. Trends Endocrinol Metab 27, 820–830, https://doi.org/10.1016/j.tem.2016.07.002 (2016). · DOI · Paper page
  2. Nerpin, E. et al. Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort. Diabetes Care 31, 1550–1555, https://doi.org/10.2337/dc08-0369 (2008). · DOI
  3. Parvanova, A. I. et al. Insulin Resistance and Microalbuminuria: A Cross-Sectional, Case-Control Study of 158 Patients With Type 2 Diabetes and Different Degrees of Urinary Albumin Excretion. Diabetes 55, 1456–1462, https://doi.org/10.2337/db05-1484 (2006). · DOI · Paper page
  4. Kim, Y. et al. Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes research and clinical practice 52, 145–152 (2001). · DOI
  5. Sarafidis, P. A. & Ruilope, L. M. Insulin resistance, microalbuminuria, and chronic kidney disease. Current hypertension reports 10, 249 (2008). · DOI
  6. Mizushima, N. Autophagy: process and function. Genes Dev 21, 2861–2873, https://doi.org/10.1101/gad.1599207 (2007). · DOI · Paper page
  7. Xu, D. et al. Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes. Acta Pharmacol Sin 35, 1215–1225, https://doi.org/10.1038/aps.2014.39 (2014). · DOI
  8. Sailaja Devi, M. M. & Das, U. N. Effect of prostaglandins against alloxan-induced diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 74, 39–60, https://doi.org/10.1016/j.plefa.2005.09.003 (2006). · DOI
  9. Bevegård, S. & Orö, L. Effect of prostaglandin E1 on forearm blood flow. Scandinavian journal of clinical and laboratory investigation 23, 347–353 (1969). · doi:10.3109/00365516909081700
  10. Zhao, L. Lu, J. Wang, C. Zhao, W. Qing, E. Ma, J. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting. J Cardiothorac Vasc Anesth 27, 208–1211, https://doi.org/10.1053/j.jvca.2013.07.001 (2013). · doi:10.1053/j.jvca.2013.07.001
  11. Ninomiya, Y. & Arakawa, M. Renal effects of prostaglandin E1 in type 2 (non-insulin-dependent) diabetic patients with subclinical nephropathy. Diabetes Research 10, 129–134 (1989).
  12. Okada, S. et al. Effect of prostaglandin E1 on the renin-aldosterone system in patients with diabetic nephropathy. Journal of International Medical Research 21, 126 (1993). · doi:10.1177/030006059302100302
  13. Sears, B. & Perry, M. The role of fatty acids in insulin resistance. Lipids Health Dis 14, 121, https://doi.org/10.1186/s12944-015-0123-1 (2015). · DOI · Paper page
  14. Khan, M. J. et al. Inhibition of autophagy rescues palmitic acid-induced necroptosis of endothelial cells. J Biol Chem 287, 21110–21120, https://doi.org/10.1074/jbc.M111.319129 (2012). · DOI · Paper page
  15. Xin, W. et al. Acetyl-CoA carboxylase 2 suppression rescues human proximal tubular cells from palmitic acid induced lipotoxicity via autophagy. Biochem Biophys Res Commun 463, 364–369, https://doi.org/10.1016/j.bbrc.2015.05.070 (2015). · DOI
  16. Zhu, S. et al. Inhibition of Kupffer Cell Autophagy Abrogates Nanoparticle-Induced LiverInjury. Adv Healthc Mater 6, https://doi.org/10.1002/adhm.201601252 (2017). · DOI
  17. Wei, Y. M. et al. Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes. Cell Physiol Biochem 31, 925–937, https://doi.org/10.1159/000350111 (2013). · DOI · Paper page
  18. Malik, R. A. et al. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. The Lancet 352, 1978–1981, https://doi.org/10.1016/s0140-6736(98)02478-7 (1998). · DOI · Paper page
  19. Bilous, R. et al. Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in DiabetesThree Randomized Trials. Annals of internal medicine 151, 11–20 (2009). · DOI · Paper page
  20. Vargas, A. V., Krishnamurthi, V., Masih, R., Robinson, A. V. & Schulak, J. A. Prostaglandin E1 attenuation of ischemic renal reperfusion injury in the rat. Journal of the American College of Surgeons 180, 713–717 (1995).
  21. Schneider, A. et al. Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: Possible role of TGFβ. Kidney international 50, 190–199 (1996). · DOI
  22. Sun, D., Liu, C. X., Ma, Y. Y. & Zhang, L. Protective effect of prostaglandin E1 on renal microvascular injury in rats of acute aristolochic acid nephropathy. Ren Fail 33, 225–232, https://doi.org/10.3109/0886022X.2010.541586 (2011). · DOI
  23. Boden, G. Obesity and free fatty acids. Endocrinol Metab Clin North Am 37, 635–646, viii-ix, https://doi.org/10.1016/j.ecl.2008.06.007 (2008). · DOI · Paper page
  24. Okumura, T., Kanemaki, T. & Kitade, H. Stimulation of glucose incorporation into glycogen by E-series prostaglandins in cultured rat hepatocytes. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1176, 137–142 (1993). · DOI
  25. Yamahara, K. et al. The role of autophagy in the pathogenesis of diabetic nephropathy. J Diabetes Res 2013, 193757, https://doi.org/10.1155/2013/193757 (2013). · DOI · Paper page
  26. Niso-Santano, M. et al. Novel inducers of BECN1-independent autophagy: cis-unsaturated fatty acids. Autophagy 11, 575–577, https://doi.org/10.1080/15548627.2015.1017222 (2015). · doi:10.1080/15548627.2015.1017222
  27. Fang, Y., Zhang, H., Zhong, Y. & Ding, X. Prolyl hydroxylase 2 (PHD2) inhibition protects human renal epithelial cells and mice kidney from hypoxia injury. Oncotarget 7, 54317 (2016). · DOI
  28. Zhao, X. et al. Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells. Int J Mol Med 35, 684–692, https://doi.org/10.3892/ijmm.2014.2052 (2015). · DOI · Paper page
  29. Zhang, N., Cao, M. M., Liu, H., Xie, G. Y. & Li, Y. B. Autophagy regulates insulin resistance following endoplasmic reticulum stress in diabetes. J Physiol Biochem 71, 319–327, https://doi.org/10.1007/s13105-015-0384-1 (2015). · DOI
  30. Shi, L. et al. Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1alpha-Sirt3 signaling pathway. Endocrine 50, 378–389, https://doi.org/10.1007/s12020-015-0599-5 (2015). · DOI
  31. Kimura, T. et al. Autophagy protects kidney proximal tubule epithelial cells from mitochondrial metabolic stress. Autophagy 9, 1876–1886, https://doi.org/10.4161/auto.25418 (2013). · DOI · Paper page
  32. Yoshizaki, T. Autophagy in Insulin Resistance. Anti-Aging Medicine 9, 180–184 (2012).
  33. Li, K. et al. The effects of fibroblast growth factor-21 knockdown and over-expression on its signaling pathway and glucose-lipid metabolism in vitro. Mol Cell Endocrinol 348, 21–26, https://doi.org/10.1016/j.mce.2011.07.026 (2012). · DOI
  34. Kim, H. W. et al. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice. Endocrinology 154, 3366–3376, https://doi.org/10.1210/en.2012-2276 (2013). · DOI
  35. Zhang, C. et al. Attenuation of hyperlipidemia-and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation. PloS one 8, e82275 (2013). · DOI · Paper page
  36. Brooks, N. E. et al. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and beta-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice. Growth Horm IGF Res 30–31, 22–30, https://doi.org/10.1016/j.ghir.2016.08.003 (2016). · DOI
  37. Wang, H., Deng, J. L., Yue, J., Li, J. & Hou, Y. B. Prostaglandin E1 for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev, CD006872, https://doi.org/10.1002/14651858.CD006872.pub2 (2010). · DOI
  38. Luo, C. et al. Therapeutic effect of alprostadil in diabetic nephropathy: possible roles of angiopoietin-2 and IL-18. Cell Physiol Biochem 34, 916–928, https://doi.org/10.1159/000366309 (2014). · DOI
  39. Lee, N. et al. Effect of misoprostol (PGE1) on glucose metabolism in type‐2‐diabetic and control subjects. Diabetes, Obesity and Metabolism 4, 195–200 (2002). · DOI
  40. Jocks, T. et al. Prostaglandin E1 reduces the glomerular mRNA expression of monocyte-chemoattractant protein 1 in anti-thymocyte antibody-induced glomerular injury. Journal of the American Society of Nephrology 7, 897–905 (1996). · DOI
  41. Nakayama, Y. et al. Long-term observation of renal function on combination therapy with prostaglandin and angiotensin-converting enzyme inhibitor for chronic kidney disease. Clinical nephrology 69, 402–407 (2008). · doi:10.5414/cnp69402
  42. Mahmoud, I. M., Hussein Ael, A., Sarhan, M. E., Awad, A. A. & El Desoky, I. Role of combined L-arginine and prostaglandin E1 in renal ischemia-reperfusion injury. Nephron Physiol 105, p57–65, https://doi.org/10.1159/000100425 (2007). · DOI
  43. Reynolds, A. et al. Induction of the interferon response by siRNA is cell type- and duplex length-dependent. Rna-a Publication of the Rna Society 12, 988–993 (2006). · DOI · Paper page
  44. Ji, K. et al. Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1alpha pathway. Free Radic Biol Med 84, 161–170, https://doi.org/10.1016/j.freeradbiomed.2015.03.020 (2015). · DOI
  45. Choi, S. E. et al. Protective role of autophagy in palmitate-induced INS-1 beta-cell death. Endocrinology 150, 126–134, https://doi.org/10.1210/en.2008-0483 (2009). · DOI · Paper page
  46. Reed, M. J. et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49, 1390–1394, https://doi.org/10.1053/meta.2000.17721 (2000). · DOI · Paper page
  47. Okita, K. et al. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocrine journal 60, 283–290 (2013). · DOI

Cited by

See all 117

Metadata

Authors
Wei, W., An, X.-R., Jin, S.-J., Li, X.-X., & Xu, M.
Venue
Scientific Reports
Published
2018-01-08
Volume
8
Issue
1
Pages
9-9
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2782491382
Cited by
117
References
11
FWCI
17.10
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of insulin resistance by PGE1 via autophagy-dependent FGF21 pathway in diabetic nephropathy. https://app.cochat.ai/papers/10.1038/s41598-017-18427-2
The paper
Wei, W., An, X.-R., Jin, S.-J., Li, X.-X., & Xu, M. (2018). Inhibition of insulin resistance by PGE1 via autophagy-dependent FGF21 pathway in diabetic nephropathy. Scientific Reports. https://doi.org/10.1038/s41598-017-18427-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.